A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...

Codex will remain free, and Deep Research just got better ...

Hundreds of millions of years before dinosaurs, the tallest things on land were not trees or animals but towering, trunk-like ...

Scientists have made a breakthrough in understanding how Alzheimer’s disease develops, and a decades-old drug could be the ...

By 24 weeks, LDL levels fell by about 57% in the enlicitide group while inching up slightly in the placebo group. The pill also lowered other blood markers tied to risk, including non-HDL cholesterol, ...

“We are learning more about how people exposed to trauma learn to distinguish between what is safe and what is not." Research shows how a common form of trauma can seriously alter brain chemistry: ...

A new study explores exercise mimetics as novel therapeutics for depression by triggering muscle-to-brain signals that support mood regulation and resilience.

What began as a search for hormone-processing enzymes ultimately transformed the treatment of high cholesterol.

Q4 2025 Earnings Call February 12, 2026 8:30 AM ESTCompany ParticipantsJoe KostkaFrank Laukien - Chairman, CEO ...

Even in the best-case scenario, it’s incredibly disruptive. And this is where you’ve been quoted saying that A.I. will disrupt 50 percent of entry-level white-collar jobs. On a five-year time horizon, ...

Dose-escalating study will evaluate the safety, tolerability and exposure of STK-002 in people with ADOA––Changes in visual ...

A randomized controlled study found that time-restricted feeding—a form of intermittent fasting—significantly reduced symptomatic disease activity and systematic inflammation in adults with Crohn's ...